Predicting Zika virus structural biology: Challenges and opportunities for interventionCombinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon systemStructural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based designMesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activityA throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoVAnti-human immunodeficiency virus type 1 (HIV-1) activity of 2'-fluoro-2',3'-dideoxyarabinosyladenine (F-ddA) used in combination with other mechanistically diverse inhibitors of HIV-1 replicationCharacterization of human immunodeficiency virus type 1 resistant to modified cyclodextrin sulphate (mCDS71) in vitroPMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanismsSynthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5'-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agentsAZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agentPlant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirusImportance of the alanine methyl ester side chain for the biological activity profile of dual-function phenyl phosphate derivatives of bromo-methoxy-zidovudineA novel peptide aldehyde with activity against human cytomegalovirus in two different in vivo modelsTSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activityAntiviral effect of brassinosteroids against herpes virus and arenavirusesInfluence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitroSynthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsIsolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolitesInhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivativePyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1Synthesis and antiviral activity of 6-benzoyl-benzoxazolin-2-one and 6-benzoyl-benzothiazolin-2-one derivativesHuman cytomegalovirus: challenges, opportunities and new drug developmentStructure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virusNovel 6-azapyrimidine-2'-deoxy-4'-thionucleosides: synthesis, biological evaluation and conformational analysisThe design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinaseIsoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latencyCharacterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217Neoglycolipid conjugates of foscarnet with enhanced antiviral activity in cells infected with human cytomegalovirus and herpes simplex virus type 1New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.The threat of avian influenza H5N1: 'do we have the tools for the job'?Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza.Combinations of L-NG-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice.Peptide inhibitors against influenza virus.Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus.Furano pyrimidines as novel potent and selective anti-VZV agents.Antiviral activity of mixed-valence rare earth borotungstate heteropoly blues against influenza virus in mice.Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain.The herpesvirus proteases as targets for antiviral chemotherapy.
P1433
Q24700044-869D83F5-ECA3-4B9E-A67C-463FDE3EE72DQ27489596-62B49127-1A3B-4FD2-971D-E38DEAD97D98Q27667923-2E10FE6C-D7EF-4FCA-B383-8D263629A5F9Q28246933-80640A54-9A26-4A54-9096-FE1CF97B1972Q28250266-FE839698-3F79-4C42-849C-7B158243CA5CQ28369925-9B28CFEF-0F2B-4DF9-94A6-7B32525E6D07Q28371764-F7C76B9A-A289-4BCB-8084-A1BFF4D0D0D9Q28371767-7C3B9E2B-950D-43FB-BE21-3F3B16B78561Q28371773-69B29BDB-4C98-4718-8356-0331BB9BF32EQ28371775-957EF7E5-4DEC-4D0C-A6FC-41CB57FF733EQ28371850-5131B270-D644-49F5-AD42-83416CF2911BQ28371854-E3839207-7528-4297-9CEA-C352467AEBAEQ28371858-A04FFBE7-EC81-41D5-AD3B-C45EEB317469Q28371862-93FE7693-A6B6-45E4-BEF0-886100C94201Q28371865-61EB7383-22AB-43E0-AB31-044E321BBC27Q28372624-08C8DAFF-103E-4B7A-97BF-BD77E92ED2E0Q28372628-7ECC4185-1011-4801-B617-4B75402C2D15Q28372635-D088FD79-A7EE-4394-8067-8C910EC6198CQ28376469-D00AFD5A-CA5B-4F56-8D54-F05B5BA601F9Q28376476-6D009358-4262-4561-A593-6C8727207AC7Q28376481-19DE4E78-5C2E-45C1-81C6-4E03BCCE4D1EQ28376487-05CDC6EE-B41C-401B-91EB-005EFAB22E0BQ28376935-4F4F261D-0901-41CD-AD65-B2987985E15EQ28376938-AC8604AD-57C8-42D8-86D9-D9D9AA849ED5Q28376943-0B33CFFA-1B54-45C5-9EFF-6C29EF3D90DBQ28376948-328662C0-AB53-4322-B73E-E32C99E40331Q28376959-90A3742A-0E02-4DB2-B553-0B06B7CCBCCCQ28378595-2BF3910E-F4D2-499E-80DA-C29EB5FDA686Q28378599-63D4C064-091D-4B95-A7A6-2D93D0B185EBQ30332341-B0B14022-DDD0-4576-BD55-83E672028588Q30362060-7CC97A90-D872-4FA1-A789-C9ADC05B535DQ30384138-9B38C03B-FECE-44FB-B716-4ABC9F4F5390Q30396669-973BB200-A699-4D72-9876-59CAB2837B22Q30401138-94200559-3F51-44DE-9F35-57CFCC081E94Q30403020-F945149C-2F15-4DB9-8AAD-0832F4EDC896Q30403023-FE0A8AC3-3E48-4D0C-9031-3909F1AFBD3BQ30659427-D358B323-28DA-4611-8E00-FCFECAB4ECA6Q30659962-94333C98-584C-456D-8F9F-D8F7C752C782Q30776145-F4B6AFE1-E2A0-4659-A9ED-1D80470AA879Q30842506-75A7D7A2-C910-4C77-8658-0C5A86C54CEA
P1433
description
journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van International Medical Press
@nl
wissenschaftliche Zeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Antiviral Chemistry & Chemotherapy
@ast
Antiviral Chemistry & Chemotherapy
@br
Antiviral Chemistry & Chemotherapy
@co
Antiviral Chemistry & Chemotherapy
@da
Antiviral Chemistry & Chemotherapy
@de
Antiviral Chemistry & Chemotherapy
@en
Antiviral Chemistry & Chemotherapy
@es
Antiviral Chemistry & Chemotherapy
@fi
Antiviral Chemistry & Chemotherapy
@fr
Antiviral Chemistry & Chemotherapy
@id
type
label
Antiviral Chemistry & Chemotherapy
@ast
Antiviral Chemistry & Chemotherapy
@br
Antiviral Chemistry & Chemotherapy
@co
Antiviral Chemistry & Chemotherapy
@da
Antiviral Chemistry & Chemotherapy
@de
Antiviral Chemistry & Chemotherapy
@en
Antiviral Chemistry & Chemotherapy
@es
Antiviral Chemistry & Chemotherapy
@fi
Antiviral Chemistry & Chemotherapy
@fr
Antiviral Chemistry & Chemotherapy
@id
altLabel
Antiviral Chemistry and Chemotherapy
@en
prefLabel
Antiviral Chemistry & Chemotherapy
@ast
Antiviral Chemistry & Chemotherapy
@br
Antiviral Chemistry & Chemotherapy
@co
Antiviral Chemistry & Chemotherapy
@da
Antiviral Chemistry & Chemotherapy
@de
Antiviral Chemistry & Chemotherapy
@en
Antiviral Chemistry & Chemotherapy
@es
Antiviral Chemistry & Chemotherapy
@fi
Antiviral Chemistry & Chemotherapy
@fr
Antiviral Chemistry & Chemotherapy
@id
P31
P921
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Antivir. Chem. Chemother.
P1277
P1476
Antiviral Chemistry & Chemotherapy
@en